On Thursday, GE Healthcare announced the opening of its first 5G Innovation Lab outside of the United States in India.
According to the business, 5G has the ability to disrupt the patient care continuum by reshaping diagnosis, therapy, and prognosis. It has the advantage of large capacity, fast data rates, low latency, and very reliable connectivity.
According to a business release, "The 5G Innovation Lab is designed to position GE Healthcare at the forefront of these innovative advancements in patient care, including potentially bringing cutting-edge technology to rural and suburban communities."
The lab will act as a testbed for developing future-ready products and solutions, marking a new frontier in innovation, according to GE Healthcare. It is located in the John F. Welch Technology Centre (JFWTC) Bengaluru, the company's largest R&D facility outside of the United States.
Modern infrastructure is housed there, including a private 5G network for research and development. For academics, the healthcare sector, and entrepreneurs, it offers expertise and a platform for a collaborative ecosystem, promoting research and enabling validation and qualification of 5G-enabled "Precision Healthcare" use cases, according to the statement.
5G in Healthcare is expected to generate revenues of USD 3,667 million by 2026, up from an estimated USD 215 million in 2021. By enabling the swift gathering and transfer of big data files and real-time, high-definition video, which can facilitate quicker analytical insights and streamline clinical decision-making, 5G might play a significant role in revolutionizing the patient experience, according to the business.
According to Jan Makela, President & CEO, Imaging at GE Healthcare, "India is a significant market for us worldwide, and it is absolutely the appropriate time to enter into 5G, which will open a realm of fascinating potential, driving the next wave of growth in Healthcare."
In order to facilitate the interaction of exponential technologies like AI/ML, IoT, Big Data, Edge Computing, and cybersecurity, the GE
Healthcare 5G Innovation Lab will act as a conduit, according to the statement.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.